Peter J. Pitts

Posts by

MedCity Influencers, Legal

Ticking the Talons of Healthcare Transparency

As of January 1, employer-sponsored Group Health Plans and Health Insurance Issuers must make make the prices of 500 medical services available via an Internet-based tool. The Transparency in Coverage final rule gets even tougher on January 1, 2024, when the prices of all medical services must be made available via an Internet-based tool.

MedCity Influencers

340B drug discount program: Stop the abuse

Some major American healthcare providers are padding their bottom lines by exploiting a federal program meant to help low-income patients. This behavior is netting them billions in ill-gotten gains. And it could be preventing many vulnerable Americans from accessing the low-cost drugs they need to treat and prevent illness. This abuse needs to be stopped. […]

presented by
MedCity Influencers

AD Hoc

We should all pay attention to our nomenclature. It’s not about “conflict of interest” — it’s about (as Secretary Sebelius correctly says) “interest.” And having an “interest” is not necessarily a bad thing — as long as you’re transparent about it. When it comes to “transparency,” we need to weigh “interest versus benefit.” Case in […]

MedCity Influencers

Fat, drunk, stupid… and uninsured

Yes Virginia, there is an interstate commerce clause. And there may yet be coal in your stocking. As you no doubt know already, Judge Hudson found that Congress could not order individuals to buy health insurance. In a 42-page opinion, Hudson said the provision of the law that requires most individuals to get insurance or […]

MedCity Influencers

An Obama tax credit to boost biopharma, R&D

Obama's proposal would allow companies to take a 17 percent deduction above 50 percent of R&D costs. Research and development are at the heart of America's most vibrant industries. Case in point: The biopharmaceutical sector. Biopharma innovation is usually noteworthy for saving lives. Three years after introducing the first antiretroviral treatments, AIDS deaths dropped 70 percent, and new pharmaceuticals are largely responsible for cutting cancer death rates in half .